You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0330 Long-term administration of tocilizumab increases the structural remission rate year by year and continuously inhibits radiographic progression: 3 year results from michinoku tocilizumab study group

Article metrics

Article menu
Download PDFPDF
Abstracts accepted for publication
Rheumatoid arthritis - other biologic treatment
AB0330 Long-term administration of tocilizumab increases the structural remission rate year by year and continuously inhibits radiographic progression: 3 year results from michinoku tocilizumab study group

 

Online download statistics by month:

Online download statistics by month: February 2014 to December 2023

AbstractFullPdf
Feb 2014501
Mar 2014800
Apr 2014200
May 2014200
Jul 2014100
Aug 2014100
Sep 2014500
Oct 2014201
Nov 2014101
Dec 2014100
Jan 2015100
Mar 2015301
Apr 2015100
Jul 2015100
Aug 2015401
Sep 2015500
Jan 2016100
Mar 2016200
May 2016101
Jun 2016100
Jul 2016400
Aug 2016400
Sep 2016300
Oct 2016900
Nov 2016500
Dec 2016600
Jan 2017500
Feb 2017300
Mar 2017700
Apr 2017300
May 20171100
Jun 2017200
Jul 2017200
Aug 2017400
Sep 2017200
Oct 2017200
Nov 2017200
Dec 2017800
Jan 2018600
Feb 2018200
Mar 2018600
Apr 20181000
May 2018600
Jun 2018600
Jul 2018400
Aug 20181800
Sep 2018400
Oct 2018400
Nov 2018400
Jan 2019400
Feb 2019600
Apr 2019200
May 2019200
Jul 2019200
Feb 2020200
Mar 2020200
Jun 2020100
Jul 2020200
Sep 2020600
Oct 2020200
Nov 2020200
Dec 2020401
Jan 2021200
May 2021200
Jul 2021100
Nov 2021200
Dec 20211000
Feb 2022400
Mar 2022400
May 2022800
Jul 20221600
Aug 2022601
Sep 2022200
Oct 2022200
Nov 2022400
Dec 2022600
Feb 2023400
Mar 2023200
May 2023400
Jul 2023200
Aug 2023200
Sep 2023600
Nov 2023200
Dec 2023600
Total33408